Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in LRMR — Larimar Therapeutics, Inc.

CIK 916542 Boston, MA
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$175,201
-$92,463 QoQ
Shares Held
57,443
-3.4% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 162 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. LRMR ranks #121 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in LRMR

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $175,201 57,443
2026-03-31 $267,664 59,481
2025-12-31 $246,392 64,670
2025-03-31 $114,463 53,239
2023-12-31 $103,248 22,692
2023-09-30 $141,990 35,947
2023-06-30 $398,220 127,227
2023-03-31 $332,606 73,423
2021-06-30 $4,487 457
2020-06-30 $258,362 20,106